The role of female obesity on in vitro fertilization outcomes

Gynecol Endocrinol. 2018 Mar;34(3):184-188. doi: 10.1080/09513590.2017.1391209. Epub 2017 Oct 16.

Abstract

The aim of this review is to analyze the role of obesity on fertility outcome in women undergoing in vitro fertilization (IVF) with respect to clinical or live birth rates and pregnancy loss rates. Despite findings from several earlier and newer studies that obesity does not adversely affect pregnancy outcome in women attempting conception, numerous reports from mostly recent studies suggest that obesity undoubtedly impairs IVF outcomes. Obesity impairs ovarian responsiveness to gonadotrophin stimulation, requiring higher doses of medication, increased risk of cycle cancelation, pre-term delivery, low birth weight or miscarriage, and decreases implantation, clinical pregnancy or live birth rates compared to women of normal weight. The mechanisms underlying the adverse effects of female obesity on IVF outcome may be primarily explained by functional alterations to the hypothalamic-pituitary-ovarian axis. Additionally, obesity appears to affect deleteriously the number and quality of oocytes or embryos, and impairs endometrial decidualization which is necessary for uterine receptivity. Nevertheless, attaining normal body weight by the use of lifestyle modifications, including a healthy diet and exercise over time of several months before and during an IVF treatment, may be successful in achievement of gradual and sustainable weight loss with improvement of IVF outcome.

Keywords: Female obesity; IVF; pregnancy outcome; underlying mechanisms.

Publication types

  • Review

MeSH terms

  • Embryo Implantation
  • Female
  • Fertility
  • Fertilization in Vitro / methods*
  • Humans
  • Obesity*
  • Ovulation Induction / methods*
  • Pregnancy
  • Pregnancy Outcome*
  • Pregnancy Rate*